320 related articles for article (PubMed ID: 21300618)
101. Risk stratification of cervical lesions using capture sequencing and machine learning method based on HPV and human integrated genomic profiles.
Tian R; Cui Z; He D; Tian X; Gao Q; Ma X; Yang JR; Wu J; Das BC; Severinov K; Hitzeroth II; Debata PR; Xu W; Zhong H; Fan W; Chen Y; Jin Z; Cao C; Yu M; Xie W; Huang Z; Bao Y; Xie H; Yao S; Hu Z
Carcinogenesis; 2019 Oct; 40(10):1220-1228. PubMed ID: 31102403
[TBL] [Abstract][Full Text] [Related]
102. Human papillomavirus genotype-specific risk in cervical carcinogenesis.
So KA; Lee IH; Lee KH; Hong SR; Kim YJ; Seo HH; Kim TJ
J Gynecol Oncol; 2019 Jul; 30(4):e52. PubMed ID: 31074234
[TBL] [Abstract][Full Text] [Related]
103. HPV type attribution in high-grade cervical lesions: assessing the potential benefits of vaccines in a population-based evaluation in the United States.
Hariri S; Unger ER; Schafer S; Niccolai LM; Park IU; Bloch KC; Bennett NM; Steinau M; Johnson ML; Markowitz LE;
Cancer Epidemiol Biomarkers Prev; 2015 Feb; 24(2):393-9. PubMed ID: 25416715
[TBL] [Abstract][Full Text] [Related]
104. Comparison of HPV DNA testing in cervical exfoliated cells and tissue biopsies among HIV-positive women in Kenya.
De Vuyst H; Chung MH; Baussano I; Mugo NR; Tenet V; van Kemenade FJ; Rana FS; Sakr SR; Meijer CJ; Snijders PJ; Franceschi S
Int J Cancer; 2013 Sep; 133(6):1441-6. PubMed ID: 23444059
[TBL] [Abstract][Full Text] [Related]
105. Associations of high-risk HPV types and viral load with cervical cancer in China.
Wu Y; Chen Y; Li L; Yu G; Zhang Y; He Y
J Clin Virol; 2006 Mar; 35(3):264-9. PubMed ID: 16183329
[TBL] [Abstract][Full Text] [Related]
106. Risk of first cervical HPV infection and pre-cancerous lesions after onset of sexual activity: analysis of women in the control arm of the randomized, controlled PATRICIA trial.
Castellsagué X; Paavonen J; Jaisamrarn U; Wheeler CM; Skinner SR; Lehtinen M; Naud P; Chow SN; Del Rosario-Raymundo MR; Teixeira JC; Palmroth J; de Carvalho NS; Germar MJ; Peters K; Garland SM; Szarewski A; Poppe WA; Romanowski B; Schwarz TF; Tjalma WA; Bosch FX; Bozonnat MC; Struyf F; Dubin G; Rosillon D; Baril L;
BMC Infect Dis; 2014 Oct; 14():551. PubMed ID: 25927224
[TBL] [Abstract][Full Text] [Related]
107. Efficacy of human papillomavirus-16 vaccine to prevent cervical intraepithelial neoplasia: a randomized controlled trial.
Mao C; Koutsky LA; Ault KA; Wheeler CM; Brown DR; Wiley DJ; Alvarez FB; Bautista OM; Jansen KU; Barr E
Obstet Gynecol; 2006 Jan; 107(1):18-27. PubMed ID: 16394035
[TBL] [Abstract][Full Text] [Related]
108. Clinical outcomes of abnormal cervical cytology and human papillomavirus-related lesions in patients with organ transplantation: 11-year experience at a single institution.
Tanaka Y; Ueda Y; Kakuda M; Kubota S; Matsuzaki S; Nakagawa S; Egawa-Takata T; Matsuzaki S; Kobayashi E; Yoshino K; Kimura T
Int J Clin Oncol; 2016 Aug; 21(4):730-734. PubMed ID: 26694812
[TBL] [Abstract][Full Text] [Related]
109. Increased risk of oncogenic human papillomavirus infections and incident high-grade cervical intraepithelial neoplasia among smokers: experience from the Latin American screening study.
Sarian LO; Hammes LS; Longatto-Filho A; Guarisi R; Derchain SF; Roteli-Martins C; Naud P; Erzen M; Branca M; Tatti S; de Matos JC; Gontijo R; Maeda MY; Lima T; Costa S; Syrjänen S; Syrjänen K
Sex Transm Dis; 2009 Apr; 36(4):241-8. PubMed ID: 19265732
[TBL] [Abstract][Full Text] [Related]
110. Prevalence of human papillomavirus and subtype distribution in male partners of women with cervical intraepithelial neoplasia (CIN): a systematic review.
Skoulakis A; Fountas S; Mantzana-Peteinelli M; Pantelidi K; Petinaki E
BMC Infect Dis; 2019 Feb; 19(1):192. PubMed ID: 30808285
[TBL] [Abstract][Full Text] [Related]
111. Progression of HPV infection to detectable cervical lesions or clearance in adult women: Analysis of the control arm of the VIVIANE study.
Skinner SR; Wheeler CM; Romanowski B; Castellsagué X; Lazcano-Ponce E; Del Rosario-Raymundo MR; Vallejos C; Minkina G; Pereira Da Silva D; McNeil S; Prilepskaya V; Gogotadze I; Money D; Garland SM; Romanenko V; Harper DM; Levin MJ; Chatterjee A; Geeraerts B; Struyf F; Dubin G; Bozonnat MC; Rosillon D; Baril L;
Int J Cancer; 2016 May; 138(10):2428-38. PubMed ID: 26685704
[TBL] [Abstract][Full Text] [Related]
112. [Study on the correlation between human papillomavirus infection and cervical lesion among women living in community of Beijing].
Zhao C; Li J; Tu Z; Song D; Cui SH; Zhang WH; Qiao YL; Wang JL; Belinson J; Wei LH
Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Oct; 28(10):947-50. PubMed ID: 18399136
[TBL] [Abstract][Full Text] [Related]
113. Methylation testing for the detection of recurrent cervical intraepithelial neoplasia.
Dick S; Heideman DAM; Mom CH; Meijer CJLM; Berkhof J; Steenbergen RDM; Bleeker MCG
Int J Cancer; 2023 Dec; 153(12):2011-2018. PubMed ID: 37539971
[TBL] [Abstract][Full Text] [Related]
114. HPV16-Related Cervical Cancers and Precancers Have Increased Levels of Host Cell DNA Methylation in Women Living with HIV.
Kremer WW; van Zummeren M; Heideman DAM; Lissenberg-Witte BI; Snijders PJF; Steenbergen RDM; Dreyer G; Meijer CJLM
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30360578
[TBL] [Abstract][Full Text] [Related]
115. HPV genotypes and cervical intraepithelial neoplasia in a multiethnic cohort in the southeastern USA.
Vidal AC; Smith JS; Valea F; Bentley R; Gradison M; Yarnall KS; Ford A; Overcash F; Grant K; Murphy SK; Hoyo C
Cancer Causes Control; 2014 Aug; 25(8):1055-62. PubMed ID: 24928693
[TBL] [Abstract][Full Text] [Related]
116. Progression from human papillomavirus (HPV) infection to cervical lesion or clearance in women (18-25 years): Natural history study in the control arm subjects of AS04-HPV-16/18 vaccine efficacy study in China between 2008 and 2016.
Welby S; Rosillon D; Feng Y; Borys D
Expert Rev Vaccines; 2022 Mar; 21(3):407-413. PubMed ID: 34939897
[TBL] [Abstract][Full Text] [Related]
117. Immunosuppressive cytokine Interleukin-10 (IL-10) is up-regulated in high-grade CIN but not associated with high-risk human papillomavirus (HPV) at baseline, outcomes of HR-HPV infections or incident CIN in the LAMS cohort.
Syrjänen S; Naud P; Sarian L; Derchain S; Roteli-Martins C; Longatto-Filho A; Tatti S; Branca M; Erzen M; Hammes LS; Costa S; Syrjänen K
Virchows Arch; 2009 Dec; 455(6):505-15. PubMed ID: 19908064
[TBL] [Abstract][Full Text] [Related]
118. Prevalence and determinants of human papillomavirus infection and cervical lesions in HIV-positive women in Kenya.
De Vuyst H; Mugo NR; Chung MH; McKenzie KP; Nyongesa-Malava E; Tenet V; Njoroge JW; Sakr SR; Meijer CM; Snijders PJ; Rana FS; Franceschi S
Br J Cancer; 2012 Oct; 107(9):1624-30. PubMed ID: 23033006
[TBL] [Abstract][Full Text] [Related]
119. Interactions between serum folate and human papillomavirus with cervical intraepithelial neoplasia risk in a Chinese population-based study.
Yang J; Yang A; Wang Z; Wang W; Wang Z; Wang Y; Wang J; Song J; Li L; Lv W; Zhao W; Li D; Liu H; Wang C; Truong A; Zheng T; Mason TG; Ran J; Hao M
Am J Clin Nutr; 2018 Nov; 108(5):1034-1042. PubMed ID: 30247499
[TBL] [Abstract][Full Text] [Related]
120. Incident genital HPV infections and potential impact of HPV vaccines in adult women living with HIV/AIDS.
Orlando G; Frati ER; Fasolo MM; Bianchi S; Matteelli A; Mazza F; Rizzardini G; Amendola A; Tanzi E
Hum Vaccin Immunother; 2019; 15(7-8):1904-1910. PubMed ID: 30261149
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
